- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Desmoid Type-fibromatosis in Japan
Total 1469 results
-
Bristol-Myers SquibbRecruiting
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruitingRelapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)Japan
-
Eli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
ServierActive, not recruitingCholangiocarcinoma Non-resectable | Cholangiocarcinoma MetastaticJapan
-
Astellas Pharma IncAjinomoto USA, INC.CompletedType 2 Diabetes Mellitus | Diabetes Mellitus, Type IIJapan
-
NobelpharmaCompletedPlaque | Tuberous Sclerosis | Angiofibroma | Hypomelanotic MaculeJapan
-
Eli Lilly and CompanyCompletedNon-Hodgkin's Lymphoma | Solid Tumor | Metastatic Cancer | Cholangiocarcinoma | Advanced Cancer | Biliary Tract Carcinoma | Gall Bladder CarcinomaJapan
-
Merck KGaA, Darmstadt, GermanyCompleted
-
AstraZenecaEli Lilly and CompanyCompleted
-
Janssen Pharmaceutical K.K.Pharmacyclics LLC.CompletedRecurrent Mature B-cell NeoplasmsJapan
-
AstraZenecaCompletedAdvanced Solid Malignancies | Malignant LymphomaUnited Kingdom, Japan
-
NobelpharmaCompleted
-
Daiichi Sankyo Co., Ltd.CompletedAcute Myeloid LeukemiaJapan
-
Eisai Inc.CompletedLymphoma, T-cell, Peripheral | Lymphoma, T-cell, CutaneousJapan
-
Osaka UniversityUnknownDiabetes Mellitus, Type 2Japan
-
Kissei Pharmaceutical Co., Ltd.Active, not recruitingUterine Fibroids (MeSH Heading: Leiomyoma)Japan
-
Kissei Pharmaceutical Co., Ltd.Active, not recruitingUterine Fibroids (MeSH Heading: Leiomyoma)Japan
-
Novo Nordisk A/SCompleted
-
TakedaCompletedGastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and OtherJapan
-
CelgeneCompletedMyelodysplastic Syndromes | Multiple MyelomaJapan
-
NobelpharmaCompletedPlaque | Tuberous Sclerosis | Angiofibroma | Hypomelanotic MaculeJapan
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
National Cerebral and Cardiovascular CenterMinistry of Health, Labor and Welfare (Japan)TerminatedMyocardial Infarction | Impaired Glucose ToleranceJapan
-
AstraZenecaEli Lilly and CompanyCompleted
-
OncoVerity, Inc.Janssen Pharmaceutical K.K.; argenxCompleted
-
Mundipharma K.K.CompletedPeripheral T-cell LymphomaJapan
-
Novartis PharmaceuticalsCompletedTumors Characterized by Genetic Alterations in Anaplastic Lymphoma Kinase (ALK)Japan
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.TerminatedMultiple MyelomaJapan
-
Novartis PharmaceuticalsEckert & Ziegler Radiopharma GmbHRecruiting
-
Eli Lilly and CompanyCompleted
-
SymBio PharmaceuticalsTerminated
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid Leukemia | Multiple Myeloma | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Acute Lymphoid LeukemiaJapan
-
Japanese Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerJapan
-
Gilead SciencesTerminatedAcute Myeloid Leukemia | Hematologic MalignancyJapan
-
Japan Liver Oncology GroupUnknownLiver Cirrhosis | Hepatitis B | Hepatocellular Carcinoma | Hepatitis CJapan
-
HUYABIO International, LLC.CompletedNon-Hodgkin's LymphomaJapan
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedType 2 Diabetes MellitusJapan
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicJapan
-
Janssen Pharmaceutical K.K.Completed
-
Eisai Co., Ltd.CompletedRelapsed or Refractory B-cell Non-Hodgkin's LymphomaJapan
-
Novartis PharmaceuticalsTerminatedNeoplasms, HaematologicJapan
-
Kindai UniversityCompletedHepatocellular CarcinomaJapan
-
AstraZenecaWithdrawnCancer | Non Small Cell Lung Cancer | Epithelial Ovarian CancerJapan
-
GlaxoSmithKlineCompletedInfections, PapillomavirusJapan
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedType 2 Diabetes MellitusJapan